Antiplasmodial activity of faloak bark (Sterculia quadrifida, R.Br.) extract from East Nusa Tenggara, Indonesia
Abstract
The current development of antimalarial drug resistance encourages researchers to discover and develop novel antimalarials. One of its alternatives for antimalarial discovery is using medicinal plants remembering the success of artemisinin. Sterculia quardrifida R. Br. bark, locally name as faloak, is an endemic medicinal plant from East Nusa Tenggara that has been used traditionally to treat malaria. However, its antimalarial activity has not been investigated, yet. This study was aimed to evaluate the antiplasmodial activity of ethanolic extract of faloak bark against Plasmodium falciparum in vitro. Using FCR-3 P. falciparum strain, the ethanolic extract was evaluated on various concentration (1, 10, 50, and 100 μg/mL, respectively). The IC50 value was determined by the relationship between concentration and percentage of growth inhibition. The result showed that the percentage of inhibition of P. falciparum was concentration dependent, higher concentration resulting on higher percentage of inhibition with the IC50 42.399 ± 9.517 μg/mL. It can be concluded that the ethanolic extract of faloak bark have moderate antiplasmodial activity against P. falciparum in vitro.
References
WHO. World Malaria Report 2019. Geneva: World Health Organization; 2019.
MoH. Profil Kesehatan Indonesia tahun 2015. Jakarta: Ministry of Health Republic of Indonesia; 2016.
Dondorp AM. New genetic marker for piperaquine resistance in Plasmodium falciparum. Lancet Infec Dis 2017;17(2):119-21.
Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infec Dis 2016; 16(3):357-65.
https://doi.org/10.1016/S1473-3099(15)00487-9.
Chaorattanakawee S, Lon C, Jongsakul K, Gawee J, Sok S, Sundrakes S, et al. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand. Malaria J 2016;15(1):519.
https://doi.org/10.1186/s12936-016-1569-
Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infec Dis 2017;17(2):174-83.
https://doi.org/10.1016/S1473-3099(16)30415-7
Karou D, Nadembega WMC, Ouattara L, Ilboudo DP, Canini A, Nikiema JB, et al. African ethnopharmacology and new drug discovery. Med Aromat Plant Sci Biotechnol 2007;1(1):1-7.
Saragih G, Siswadi S. Antioxidant activity of plant parts extracts from Sterculia quadrifida R. Br. Asian J Pharm Clin Res 2019;12:143-8.
https://doi.org/10.22159/ajpcr.2019.v12i7.33261
Munawaroh R, Siswadi S, Setyowati EP, Murwanti R, Hertiani T. Correlation between total flavonoid contents and macrophage phagocytosis activity of fractions from faloak (Sterculia quadrifida R.Br.) barks ethanolic extract in vitro. Trad Med J 2018;23(1):47-55.
https://doi.org/10.22146/mot.30882
Winanta A, Hertiani T, Purwantiningsih P, Siswadi S. In vivo immunomodulatory activity of faloak bar extract (Sterculia quadrifida R. Br.). Pakistan J Biol Sci 2019;22(12):590-6.
https://doi.org/10.3923/pjbs.2019.590.596
Dean M, Handajani R, Khotib J. Faloak (Sterculia quadrifida R.Br) Stem bark extract inhibits hepatitis C virus JFH1. Orient J Chem 2019;35:430-5.
http://dx.doi.org/10.13005/ojc/350155
Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976;193(4254):673-5.
https://doi.org/10.1126/science.781840
Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 1979;16:710-8.
https://doi.org/10.1128/aac.16.6.710
Azwanida NN. A review on the extraction methods use in medicinal plants, principle, strength and limitation. Med Aromat Plants 2015;4(3).
https://doi.org/10.4172/2167-0412.1000196
Ghasemzadeh A, Jaafar HZE, Juraimi AS, Tayebi-Meigooni A. Comparative evaluation of different extraction techniques and solvents for the assay of phytochemicals and antioxidant activity of hashemi rice bran. Molecules 2015; 20(17): 10822-38.
https://doi.org/10.3390/molecules200610822
Siswadi S, Rianawati H, Hadi D, Saragih G, editors. The potency of faloak's (Sterculia quadrifida, R.Br.) active compounds as natural remedy. International Seminar Proceeding "Forests & Medicinal Plants for Better Human Welfare" 10-12 September 2013; 2018:73-9.
https://doi.org/10.5281/zenodo.3353788
Anandan JV. Parasitic disease. In: Burns MA, editor. Pharmacotherapy Principle and Practise. New York: Mc Graw Hill; 2008. p.1186-9.
Basco LK, Le Bras J. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Ann Trop Med Parasitol. 1994;88(2):137-44.
https://doi.org/10.1080/00034983.1994.11812851.
Dolabela MF, Oliveira SG, Nascimento JM, Peres JM, Wagner H, Povoa MM, et al. In vitro antiplasmodial activity of extract and constituents from Esenbeckia febrifuga, a plant traditionally used to treat malaria in the Brazilian Amazon. Phytomedicine. 2008;15(5):367-72.
https://doi.org/10.1016/j.phymed.2008.02.001.
Uzor PF. Alkaloids from plants with antimalarial activity: a review of recent studies. Evid Based Complement Alternat Med 2020; 2020:8749083.
https://doi.org/10.1155/2020/8749083
Ganesh D, Fuehrer HP, Starzengrüber P, Swoboda P, Khan WA, Reismann JA, et al. Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones. Parasitol Res 2012;110(6):2289-95.
https://doi.org/10.1007/s00436-011-2763-z.
Matthew AO, Olusola E, Ademola O, Aderotimi A, Adebola J. Anti-malarial activity of total saponins from Terminalia avicennioides and its effect on liver and haematological of infected mice. Drug Designing 2018;7(2): 2169-0138.1000161
Rollando R, Alfanaar R. Cytotoxic effect of 2,3-dihydro-6-hydroxy-2-methylenenaphtho[1,2-b] furan-4,5-dione compound from the bark of faloak (Sterculia quadrifida R.Br) in breast cancer cells T47D. Pharmaciana 2017;7(2): 289-94.
